Guggenheim Capital LLC Grows Holdings in Merit Medical Systems, Inc. (MMSI)

Guggenheim Capital LLC grew its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 20.7% in the fourth quarter, Holdings Channel reports. The fund owned 42,161 shares of the medical instruments supplier’s stock after acquiring an additional 7,241 shares during the period. Guggenheim Capital LLC’s holdings in Merit Medical Systems were worth $1,821,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in MMSI. SG Americas Securities LLC bought a new stake in shares of Merit Medical Systems in the 3rd quarter valued at about $189,000. JPMorgan Chase & Co. increased its stake in shares of Merit Medical Systems by 5,089.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 85,315 shares of the medical instruments supplier’s stock valued at $3,588,000 after acquiring an additional 83,671 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Merit Medical Systems by 189.2% in the 3rd quarter. Wells Fargo & Company MN now owns 324,487 shares of the medical instruments supplier’s stock valued at $13,742,000 after acquiring an additional 212,304 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of Merit Medical Systems by 5.1% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 235,869 shares of the medical instruments supplier’s stock valued at $9,990,000 after acquiring an additional 11,455 shares during the last quarter. Finally, Allianz Asset Management GmbH increased its stake in shares of Merit Medical Systems by 7.6% in the 3rd quarter. Allianz Asset Management GmbH now owns 82,205 shares of the medical instruments supplier’s stock valued at $3,481,000 after acquiring an additional 5,815 shares during the last quarter. 95.22% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

NASDAQ MMSI opened at $45.80 on Wednesday. Merit Medical Systems, Inc. has a 52-week low of $28.13 and a 52-week high of $49.50. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.73 and a quick ratio of 1.39. The company has a market cap of $2,264.67, a P/E ratio of 35.78, a price-to-earnings-growth ratio of 2.07 and a beta of 1.29.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Wednesday, February 28th. The medical instruments supplier reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.01. Merit Medical Systems had a return on equity of 9.65% and a net margin of 3.78%. The business had revenue of $190.90 million during the quarter, compared to analysts’ expectations of $187.62 million. During the same period in the prior year, the business earned $0.31 EPS. Merit Medical Systems’s revenue for the quarter was up 21.0% compared to the same quarter last year. sell-side analysts expect that Merit Medical Systems, Inc. will post 1.64 earnings per share for the current year.

A number of analysts have recently commented on the company. Zacks Investment Research cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, January 25th. BidaskClub cut Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Friday, January 26th. ValuEngine raised Merit Medical Systems from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Canaccord Genuity upped their price target on Merit Medical Systems from $50.00 to $57.00 and gave the company a “buy” rating in a research note on Thursday, March 1st. Finally, SunTrust Banks upped their price target on Merit Medical Systems from $1.64 to $55.00 and gave the company a “buy” rating in a research note on Wednesday, March 7th. Fourteen analysts have rated the stock with a buy rating, Merit Medical Systems currently has a consensus rating of “Buy” and an average target price of $48.82.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/18/guggenheim-capital-llc-grows-holdings-in-merit-medical-systems-inc-mmsi.html.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply